STOCK TITAN

XWELL, Inc. to Announce 2022 Financial Results on Monday April 17

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

XWELL, Inc. (Nasdaq: XWEL) will announce its fiscal year 2022 financial results on April 17, 2023, after market close, followed by a webcast and conference call at 5:00 PM ET. Interested investors are encouraged to listen via the webcast due to limited phone line capacity.

The Company operates four brands: XpresSpa, a leader in airport wellness services with 35 locations; Treat, a travel health brand; XpresCheck, providing COVID-19 testing; and HyperPointe, a digital healthcare analytics firm. XWELL emphasizes the importance of health and wellness solutions for travelers.

Forward-looking statements are included regarding future performance expectations, which are not guaranteed and involve risks.

Positive
  • Strategic focus on health and wellness solutions for travelers via multiple brands.
  • Diverse service offerings: wellness services, travel health, and COVID-19 screening.
Negative
  • None.

Webcast and Conference Call Scheduled for 5:00 PM ET

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release fiscal year 2022 financial results on Monday, April 17, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET.

The Company encourages investors, and interested parties, to listen via webcast as there is a limited capacity to access the conference call by dialing 1-201-689-8263.

The live and later archived webcast can be accessed from the Investor Relations section of the Company’s website at https://www.xwell.com. Visitors to the website should select the “Investors” tab and navigate to the “Events” link to access the webcast.

About XWELL, Inc.

XWELL, Inc. (Nasdaq: XWEL) is a leading global health and wellness holding company operating four brands: XpresSpa®, Treat, XpresCheck® and HyperPointe™

  • XpresSpa is a leading airport retailer of wellness services and related products, with 35 locations in 15 airports globally.
  • Treat is a travel health and wellness brand and a fully integrated concept blending technology with traditional brick and mortar offerings to provide a holistic approach to physical and mental well-being for travelers.
  • XpresCheck is a provider of COVID-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting bio-surveillance monitoring in its airport locations to identify new SARS-CoV2 variants of interest and concern as well as other pathogens entering the country from across the world.
  • HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events are based upon information available to XWELL as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings (which reports were filed under the Company’s former name, XpresSpa Group, Inc., prior to its previously announced name change effective October 25, 2022). All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Media
Heather Tidwell 
MWW  
htidwell@mww.com



FAQ

When will XWELL release its 2022 financial results?

XWELL will release its fiscal year 2022 financial results on April 17, 2023, after market close.

What time is the XWELL conference call scheduled?

The conference call for XWELL is scheduled for 5:00 PM ET on April 17, 2023.

How can I access the XWELL earnings webcast?

You can access the XWELL earnings webcast from the Investor Relations section of the company’s website.

What brands does XWELL operate?

XWELL operates four brands: XpresSpa, Treat, XpresCheck, and HyperPointe.

What services does XpresCheck provide?

XpresCheck provides COVID-19 screening and diagnostic testing.

XWELL, Inc.

NASDAQ:XWEL

XWEL Rankings

XWEL Latest News

XWEL Stock Data

8.09M
4.76M
9.65%
17.55%
1.37%
Diagnostics & Research
Services-personal Services
Link
United States of America
NEW YORK